Skip to main content
    T

    Tevogen Bio Holdings Inc. (TVGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.08
    +0.57 (+8.83%)

    Market Cap: $42.36M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(4/6)
    Avg Surprise
    -50.99%
    Streak
    2 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 13
    		$-1.52$-2.50+39.20%Beat-1.3%
    Mar 26
    Reported May 15
    		$-1.61$-2.50+35.50%Beat+53.9%
    Dec 25
    Reported Mar 31
    		$-7.96$-1.50-430.67%Miss-15207.7%
    Sep 25
    Reported Nov 14
    		$-1.50$-3.00+50.00%Beat+13.6%
    Jun 25
    Reported Aug 19
    		$-1.50$-2.50+40.00%Beat-3707.1%
    Mar 25
    Reported Apr 2
    		$-3.50$-2.50-40.00%Miss-1245.1%
    Dec 24
    Reported Dec 31
    		$-0.05N/AN/ABeat+98.1%
    Sep 24
    Reported Nov 19
    		$-1.74N/AN/ABeat-97.0%
    Jun 24
    Reported Aug 14
    		$-0.04$0.00N/ABeat+93.6%
    Mar 24
    Reported May 27
    		$-0.26$0.00N/ABeat-620.4%
    Dec 23
    Reported Dec 31
    		$-2.77N/AN/ABeat-201.8%
    Sep 23
    Reported Sep 30
    		$-0.88N/AN/ABeat-3037.3%
    Jun 23
    Reported Jun 30
    		$-0.62N/AN/ABeat-14439.5%
    Mar 23
    Reported Apr 17
    		$0.05N/AN/ABeat+10100.0%
    Dec 22
    Reported Mar 31
    		$2.73N/AN/ABeat-
    Sep 22
    Reported Nov 14
    		$0.03N/AN/ABeat-
    Jun 22
    Reported Aug 15
    		$0.00N/AN/ABeat-
    Mar 22
    Reported Jun 29
    		$-0.00N/AN/ABeat-
    Sep 21
    Reported Nov 5
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.56EV/EBITDAN/A
    Price/FCF-2.33xFCF Yield-42.91%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE0.00%ROIC2022.83%
    Financial Health
    Debt/Equity-0.91xInterest Coverage-70.90x
    Current Ratio0.33xQuick Ratio0.33x
    Trading Statistics
    Beta0.20Avg Volume5.41K
    52-Week High$36.5052-Week Low$3.64

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.78
    SMA 20$7.03
    SMA 50$6.98
    SMA 200$8.80
    EMA 10$6.86
    EMA 20$6.94
    EMA 50$6.97
    EMA 200$11.98

    MACD

    Line: -0.08Signal: -0.07Hist: -0.01

    ADX

    ADX: 31.2+DI: 9.8-DI: 22.1

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down80.0
    PSAR$5.99

    Bollinger Bands

    Upper Band$7.99
    Lower Band$6.07
    %B Position2727%(Upper)
    Band Width0.53

    RSI (14-Day)

    Neutral
    51.7

    Momentum Oscillators

    Stoch %K57.2
    Stoch %D51.0
    Williams %R-25.8
    ROC (10d)5.4%
    Momentum0.36
    CCI (20d)-34.6
    MFI (14d)52.8

    Volatility Measures

    ATR (14d)$0.57(8.0%)
    StdDev (20d)0.48
    Hist Vol81.0%(High)

    Volume Flow

    VWAP$6.85
    OBV1.0M
    AD Line216.6B
    CMF (20d)0.118

    Volume Metrics

    Avg Vol (20d)5.7K
    Vol Ratio0.3x(Low)
    VWMA (20d)$7.11

    Pivot Points

    R3$7.63
    R2$7.37
    R1$6.94
    Pivot Point$6.67
    S1$6.24
    S2$5.97
    S3$5.54

    Advanced Oscillators

    TSI-5.63
    Ultimate Osc52.3
    KST-54.34

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$396,586$0$0$0$0$0$0
    Cost of Revenue$60,144$59,051$85,786$27,225$290,784$103,547N/A$101,741$99,990$98,303$100,869$93,579
    Gross Profit$-60,144$-59,051$-85,786$-27,225$-290,784$-103,547N/A$-101,741$-99,990$-98,303$-100,869$-93,579
    Operating Expenses$5.60M$5.34M$4.52M$5.73M$5.44M$10.36M$9.42M$5.98M$8.50M$29.42M$1.91M$2.23M
    R&D$3.28M$3.13M$2.11M$3.11M$2.70M$3.20M$2.84M$3.26M$4.12M$20.81M$908,049$1.12M
    SG&A$2.38M$2.27M$2.50M$2.62M$2.74M$7.16M$6.59M$2.82M$4.47M$8.71M$933,394$1.21M
    Operating Income$-5,662,376$-5,400,920$-4,610,201$-5,729,431$-5,444,536$-10,356,347$-9,423,210$-6,085,527$-8,599,027$-29,516,724$-2,009,269$-2,325,008
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$98,387$71,166$70,674$62,340$38,033$24,571$15,798$12,459$6$155,786$256,031$299,943
    Income Before Tax$-5,761,940$-5,446,255$-4,677,580$-5,726,812$-5,503,979$-10,367,061$-9,504,552$-5,884,223$-9,663,447$11.26M$-3,632,232$-3,904,951
    Income Tax Expense$0$0$0$0$0$60,000$0$-5,884,223$-3,613,000$48.62M$-44,094$-39,735
    Net Income$-5,761,940$-5,446,255$-4,677,580$-5,726,812$-5,503,979$-10,367,061$-9,444,552$-5,909,428$-6,050,447$11.26M$-3,632,232$-3,904,951
    EBITDA$-5,602,232$-5,458,370$-4,521,120$-5,373,055$-5,477,387$-10,237,088N/A$-5,770,023$-9,563,457$11.52M$-3,213,838$-3,511,429
    EBIT$-5,662,376$-5,517,421$-4,606,906$-5,664,472$-5,503,979$-10,342,490$-9,423,210$-5,871,764$-9,663,447$11.42M$-3,314,707$-3,605,008
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TVGN

    News

    Enterprise value to EBIT forward of Tevogen Inc. – BOATS:TVGNW

    This article provides the enterprise value to EBIT forward for Tevogen Inc. (TVGNW) as listed on the Blue Ocean Alternative Trade System (BOATS). The content is very brief, showing a value, a change...

    TradingView•10/12/26•Neutral

    Price to earnings forward of Tevogen Inc. – BOATS:TVGNW

    This article provides the "Price to earnings forward" for Tevogen Inc. (TVGNW) on the Blue Ocean Alternative Trade System (BOATS). It indicates that the market is closed...

    TradingView•10/10/26•Neutral

    Tevogen Bio Signs Letter of Intent to Evaluate HRK Healthcare Acquisition

    Tevogen Bio has signed a Letter of Intent to explore the acquisition of HRK Healthcare. This development follows recent news of Tevogen Bio Holdings regaining compliance with Nasdaq's minimum market value requirement...

    marketscreener.com•10/8/26•Somewhat-Bullish

    Tevogen Bio Signs Letter of Intent to Evaluate HRK Healthcare Acquisition

    Tevogen Bio (TVGN) announced it has signed a non-exclusive, non-binding letter of intent to evaluate the acquisition of HRK Healthcare. The article is from MT Newswires and requires a premium subscription to read...

    Yahoo Finance•10/8/26•Neutral

    Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

    Tevogen Inc. announced it has signed a non-binding Letter of Intent (LoI) to evaluate a potential acquisition of HRK Healthcare LLC. This proposed transaction aims to expand Tevogen's healthcare infrastructure...

    Yahoo Finance•10/8/26•Somewhat-Bullish

    TVGN Valuation and Fair Value

    P/E
    -0.6x
    P/FCF
    -2.3x
    P/B
    -3.1x
    See GNG's fair value

    TVGN Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    2022.8%
    ROE
    0.0%
    FCF yield
    -42.9%

    TVGN Competitors

    CompanyTicker
    eXoZymes, Inc.EXOZ
    PureTech Health PLCPRTC
    Dogwood Therapeutics, Inc.DWTX
    Ekso Bionics Holdings IncEKSO
    Rapid Micro Biosystems IncRPID
    Precipio IncPRPO
    Serina Therapeutics IncSER
    Instil Bio Inc.TIL

    Sector: Healthcare

    TVGN Bull Case vs Bear Case

    Bull case

    • TVGN earns a 2022.8% return on invested capital.

    TVGN Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -68.3%

    Frequently Asked Questions About TVGN

    Does TVGN pay dividends?

    Tevogen Bio Holdings Inc. (TVGN) does not currently pay a regular dividend.

    What is TVGN's market cap?

    Tevogen Bio Holdings Inc. (TVGN) has a market capitalization of $42.36M with a current stock price of $7.08.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In